Overview
- Fantis first noticed fleeting sweet “caramel” smells—now identified as mini seizures—before an April 2024 biopsy confirmed inoperable stage 4 IDH-wildtype glioblastoma.
- He has just finished the NHS’s sole glioblastoma regimen of radiotherapy and chemotherapy, with scans showing a promising early response.
- His family has raised over £260,000 toward a £464,000 target needed to fund dendritic-cell vaccine therapy in Munich starting next week.
- They are also exploring alternative protocols abroad, including oncothermia in London, a three-phase immunotherapy trial in Cologne and peptide vaccine treatment in Tübingen.
- Frustrated by two decades of limited NHS advances for glioblastoma, the family has relied on community donations from Stoke-on-Trent and nationwide supporters to pursue experimental care.